COVID-19封锁期间治疗延迟对新生血管性年龄相关性黄斑变性患者的功能和解剖影响
该研究回顾性分析了314例(394眼)新生血管性年龄相关性黄斑变性患者,比较封锁期间继续接受玻璃体腔注射治疗(C组,n=215)与完全延迟治疗(S组,n=179)的患者。结果显示C组视力无显著变化,而S组视力显著下降且治疗后未恢复至基线;C组中心子区域厚度稳定,S组升高后恢复。作者推荐封锁期间继续治疗。
要点
- 继续注射治疗组视力在封锁前后无显著差异。
- 延迟治疗组视力较基线显著下降,恢复治疗后仅轻微改善,未恢复至基线。
- 继续治疗组中心子区域厚度稳定,延迟组升高后恢复至封锁前水平。
核心结论
- 在疫情封锁期间,仅注射策略对新生血管性年龄相关性黄斑变性患者管理有效。
- 延迟预定治疗的患者显示出部分不可逆的视功能恶化。
- 作者推荐封锁期间新生血管性年龄相关性黄斑变性患者继续治疗。
研究设计与样本
- 回顾性研究,纳入314例(394眼)预定接受玻璃体腔注射治疗的新生血管性年龄相关性黄斑变性患者。
- 比较继续接受预定玻璃体腔注射治疗但无临床咨询的患者(C组,n=215)与完全延迟治疗的患者(S组,n=179)。
- 在封锁前后四个时间点收集功能和解剖参数。
主要发现
- C组基线与封锁后视力无显著差异。
- S组视力较基线显著下降,恢复治疗后轻微改善,但未恢复至基线值。
- C组平均中心子区域厚度保持稳定,S组升高,恢复治疗后回到封锁前值。
临床怎么用
- 作者推荐在封锁期间新生血管性年龄相关性黄斑变性患者继续治疗。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: To investigate the visual and anatomical impact of intravitreal injection treatment deferral because of the COVID-19 lockdown on patients affected by neovascular age-related macular degeneration. METHODS: We retrospectively reviewed 314 patients (394 eyes) who were scheduled to receive the impact of intravitreal injections during the Swiss lockdown. We compared patients who continued to receive scheduled impact of intravitreal treatment without clinical consultation (Group Continue ‟C"; n = 215) and patients for whom the impact of intravitreal treatment was completely deferred (Group Stop, ‟S"; n = 179). Functional and anatomical parameters were collected at four time points before and after the lockdown. RESULTS: In Group C, the visual acuity at baseline and after the lockdown did not differ significantly. In Group S, the visual acuity deteriorated significantly compared with baseline and then improved slightly after the resumption of treatment, but it did not recover to baseline values. The mean central subfield thickness remained stable in Group C, whereas it increased in Group S and then returned to prelockdown values after the resumption of treatment. CONCLUSION: An "injection-only" approach was effective in managing patients with neovascular age-related macular degeneration during the pandemic lockdown, whereas patients who deferred their scheduled treatment showed partially irreversible deterioration of visual function. We recommend treatment continuation in patients with neovascular age-related macular degeneration during a lockdown.
引用
- Montesel A, Gigon A, Giacuzzo C, et al. TREATMENT DEFERRAL DURING COVID-19 LOCKDOWN: Functional and Anatomical Impact on Patients With Neovascular Age-Related Macular Degeneration. Retina. 2022. PMID: 34907122. doi:10.1097/IAE.0000000000003369
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。